Globus Medical Inc. (GMED)
NYSE: GMED
· Real-Time Price · USD
59.56
-1.04 (-1.72%)
At close: Sep 08, 2025, 3:59 PM
60.00
0.74%
After-hours: Sep 08, 2025, 06:23 PM EDT
Globus Medical Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emerging Technology Revenue | 35.16M | 22.19M | 46.95M | 38.3M | 36.78M | 31.97M | 32.71M | 27.66M | 34.76M | 25.08M | 29.5M | 24.09M | 29.41M | 13.15M | 25.4M | 20.24M | 20.75M | 14.93M | 18.08M | 9.04M | 5.44M | 8.04M | 13.91M | 13.89M | 19.19M | 7.19M | 6.28M | 13.81M | 12.78M |
| Emerging Technology Revenue Growth | +58.46% | -52.74% | +22.58% | +4.15% | +15.04% | -2.28% | +18.27% | -20.42% | +38.59% | -14.98% | +22.46% | -18.08% | +123.67% | -48.24% | +25.47% | -2.46% | +39.02% | -17.45% | +100.15% | +66.02% | -32.27% | -42.24% | +0.14% | -27.61% | +166.94% | +14.40% | -54.51% | +8.06% | n/a |
| Spine Revenue | 710.18M | 575.93M | 610.34M | 587.4M | 592.91M | 574.7M | 592.34M | 347.46M | 256.86M | 251.61M | 245M | 230.06M | 234.24M | 217.4M | 224.62M | 209.48M | 230.26M | 212.42M | 215.36M | 207.06M | 143.48M | 182.54M | 197.76M | 182.32M | 358.3M | 175.76M | 162.95M | 159.57M | 161.63M |
| Spine Revenue Growth | +23.31% | -5.64% | +3.90% | -0.93% | +3.17% | -2.98% | +70.48% | +35.27% | +2.09% | +2.70% | +6.49% | -1.79% | +7.75% | -3.21% | +7.23% | -9.03% | +8.40% | -1.37% | +4.01% | +44.31% | -21.40% | -7.69% | +8.46% | -49.11% | +103.86% | +7.86% | +2.12% | -1.27% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Sep 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Us Revenue | 144.56M | 114.26M | 135.4M | 129.92M | 130.23M | 123.74M | 125.69M | 74.32M | 46.13M | 42.57M | 41.27M | 37.12M | 38.37M | 34.15M | 37.06M | 31.55M | 35.9M | 34.03M | 34.7M | 33.99M | 23.77M | 32.13M | 34.21M | 33.52M | 34.55M | 35.41M | 32.16M | 30.14M | 28M | 28.79M | 28.02M | 25.81M | 26.12M | 26.15M | 24.11M | 120.47M | 124.72M | 127.56M | 131.05M | 125.67M | 121.49M | 119.98M | 11.65M | 106.6M | 101.63M | 101.7M | 28.77M | 98.11M | 98.11M | 96.27M | 87.14M |
| Non Us Revenue Growth | +26.51% | -15.61% | +4.22% | -0.24% | +5.25% | -1.56% | +69.12% | +61.14% | +8.36% | +3.16% | +11.16% | -3.24% | +12.36% | -7.86% | +17.46% | -12.11% | +5.50% | -1.93% | +2.07% | +43.02% | -26.03% | -6.07% | +2.06% | -2.99% | -2.43% | +10.12% | +6.69% | +7.63% | -2.74% | +2.76% | +8.55% | -1.18% | -0.10% | +8.43% | -79.98% | -3.40% | -2.23% | -2.66% | +4.28% | +3.44% | +1.25% | +930.16% | -89.07% | +4.89% | -0.07% | +253.56% | -70.68% | 0.00% | +1.91% | +10.48% | n/a |
| United States Revenue | 600.78M | 483.86M | 521.89M | 495.79M | 499.46M | 482.93M | 490.84M | 309.31M | 245.49M | 234.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 158.45M | n/a | n/a | n/a | 147.54M | 163.78M | 139.1M | 145.38M | 145.62M | 148.01M | 125.93M | 126.27M | 129.66M | 127.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 117.15M | n/a | n/a | n/a | 104.13M | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +24.17% | -7.29% | +5.26% | -0.73% | +3.42% | -1.61% | +58.69% | +26.00% | +4.86% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.92% | +17.75% | -4.32% | -0.16% | -1.62% | +17.53% | -0.27% | -2.62% | +1.71% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 303.62M | 242.8M | 253.48M | 240.74M | 238.12M | 248.71M | 244.72M | 156.21M | 120.07M | 122.42M | 118.08M | 106.58M | 106.72M | 100.75M | 106.56M | 96.44M | 107.25M | 97.89M | 92.05M | 89.15M | 80.02M | 93.54M | 92.14M | 88.45M | 88.38M | 85.78M | 83.64M | 75.13M | 77.13M | 75.69M | 72.96M | 63.36M | 64.44M | 67.06M | 60.84M | 54.21M | 52.41M | 54.57M | 53.39M | 53.83M | 54.51M | 52.29M |
| Selling, General, and Administrative Revenue Growth | +25.05% | -4.21% | +5.29% | +1.10% | -4.26% | +1.63% | +56.66% | +30.10% | -1.92% | +3.68% | +10.79% | -0.13% | +5.93% | -5.45% | +10.49% | -10.08% | +9.56% | +6.35% | +3.25% | +11.41% | -14.45% | +1.52% | +4.16% | +0.09% | +3.03% | +2.56% | +11.33% | -2.59% | +1.89% | +3.75% | +15.14% | -1.67% | -3.91% | +10.22% | +12.23% | +3.43% | -3.96% | +2.21% | -0.82% | -1.24% | +4.24% | n/a |
| Research and Development Revenue | 39.95M | 33.06M | 33.41M | 35.38M | 37.7M | 57.27M | 52.25M | 29.33M | 21.35M | 21.08M | 19.51M | 18.7M | 17.39M | 17.41M | 51.02M | 15.85M | 15.55M | 14.92M | 15.24M | 14.42M | 39.45M | 15.4M | 15.5M | 14.51M | 15.75M | 14.32M | 13.76M | 15.53M | 13.52M | 12.69M | 11.41M | 10.89M | 10.71M | 10.67M | 13.64M | 10.27M | 10.59M | 10.03M | 9.84M | 9.25M | 9.08M | 8.66M |
| Research and Development Revenue Growth | +20.85% | -1.04% | -5.57% | -6.15% | -34.17% | +9.60% | +78.16% | +37.39% | +1.26% | +8.07% | +4.31% | +7.51% | -0.10% | -65.87% | +221.84% | +1.97% | +4.17% | -2.08% | +5.69% | -63.45% | +156.17% | -0.61% | +6.81% | -7.86% | +9.93% | +4.11% | -11.39% | +14.82% | +6.57% | +11.18% | +4.83% | +1.62% | +0.44% | -21.82% | +32.91% | -3.11% | +5.62% | +1.97% | +6.34% | +1.86% | +4.91% | n/a |